Mallory Morales insider trades: Immuneering (IMRX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mallory reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 1, 2025 | IMRX | ↑ Buy | 300 | $6.39 | $2K | Direct | Oct 2, 2025 (1d) |
| Mar 22, 2024 | IMRX | ↑ Buy | 1,500 | $2.67 | $4K | Direct | Mar 25, 2024 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IMRX insiders
Open-market trades in the last 12 months
About Mallory Morales's insider trades
Mallory Morales is SVP Finance, CAO at Immuneering (IMRX). Since Mar 22, 2024, Mallory has reported 2 open-market purchases worth $6K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (10 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.